A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

Juan Camilo Arjona Ferreira net worth and biography

Juan Arjona Ferreira Biography and Net Worth

Insider of Myovant Sciences

Dr. Arjona Ferreira has served as Chief Medical Officer of Myovant Sciences Ltd. and Myovant Sciences, Inc. since July 2017. From March 2014 to July 2017, Dr. Arjona Ferreira was Senior Vice President, Clinical Development at Shionogi Inc., a pharmaceutical company, where he served on its U.S. Senior Leadership Team and the Global Scientific Committee and was responsible for leading its U.S. Clinical Development organization. From July 2002 to March 2014, Dr. Arjona Ferreira worked at Merck & Co., Inc., a pharmaceutical company, where he held positions of increased responsibility, the last being Executive Director of Clinical Research in Women’s Health and led the product development teams for all programs in contraception and women’s health. He received his M.D. and completed his postgraduate specialist training in Obstetrics and Gynecology at Colegio Mayor del Rosario in Bogota, Colombia.

What is Juan Camilo Arjona Ferreira's net worth?: The estimated net worth of Juan Camilo Arjona Ferreira is at least $6.69 million as of January 4th, 2023. Dr. Arjona Ferreira owns 247,793 shares of Myovant Sciences stock worth more than $6,685,455 as of April 24th. This net worth evaluation does not reflect any other assets that Dr. Arjona Ferreira may own. Learn More about Juan Camilo Arjona Ferreira's net worth.
How do I contact Juan Camilo Arjona Ferreira?: The corporate mailing address for Dr. Arjona Ferreira and other Myovant Sciences executives is 11-12 ST. JAMES SQUARE SUITE 1 3RD FLOOR, LONDON X0, SW1Y 4LB. Myovant Sciences can also be reached via phone at 442074003351 and via email at [email protected]. Learn More on Juan Camilo Arjona Ferreira's contact information.
Has Juan Camilo Arjona Ferreira been buying or selling shares of Myovant Sciences?: Juan Camilo Arjona Ferreira has not been actively trading shares of Myovant Sciences over the course of the past ninety days. Most recently, Ferreira Juan Camilo Arjona sold 2,251 shares of the business's stock in a transaction on Wednesday, January 4th. The shares were sold at an average price of $26.90, for a transaction totalling $60,551.90. Following the completion of the sale, the insider now directly owns 247,793 shares of the company's stock, valued at $6,665,631.70. Learn More on Juan Camilo Arjona Ferreira's trading history.
Who are Myovant Sciences' active insiders?: Myovant Sciences' insider roster includes Juan Arjona Ferreira (Insider), Matthew Lang (General Counsel), and David Marek (Insider). Learn More on Myovant Sciences' active insiders.

Juan Camilo Arjona Ferreira Insider Trading History at Myovant Sciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/4/2023	Sell	2,251	$26.90	$60,551.90	247,793
10/4/2022	Sell	2,738	$24.40	$66,807.20	251,648
7/6/2022	Sell	2,755	$13.40	$36,917.00	255,992
4/19/2022	Sell	4,632	$10.45	$48,404.40	260,129
4/5/2022	Sell	1,922	$13.78	$26,485.16
1/4/2022	Sell	2,271	$16.27	$36,949.17
11/29/2021	Sell	1,978	$19.30	$38,175.40
11/3/2021	Sell	700	$24.00	$16,800.00
10/5/2021	Sell	2,738	$21.62	$59,195.56
9/27/2021	Sell	7,000	$24.32	$170,240.00
8/30/2021	Sell	21,000	$24.05	$505,050.00	171,329
8/27/2021	Sell	1,978	$22.69	$44,880.82
7/7/2021	Sell	2,777	$21.75	$60,399.75
5/28/2021	Sell	3,083	$24.00	$73,992.00	179,167
5/26/2021	Sell	12,700	$24.23	$307,721.00	190,567
3/19/2021	Sell	7,000	$24.17	$169,190.00	141,535
12/18/2020	Sell	2,000	$26.00	$52,000.00	138,048
12/15/2020	Sell	7,000	$23.92	$167,440.00	143,048
12/10/2020	Sell	10,000	$26.04	$260,400.00	146,048
11/30/2020	Sell	1,978	$23.65	$46,779.70	136,048
8/28/2020	Sell	2,058	$20.01	$41,180.58	138,026
6/23/2020	Sell	4,054	$20.00	$81,080.00	156,061
2/15/2019	Sell	260	$21.15	$5,499.00	9,740

Juan Camilo Arjona Ferreira Buying and Selling Activity at Myovant Sciences

Myovant Sciences Company Overview

Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom.

Today's Range

Now: $26.98

$26.98

$27.00

50 Day Range

MA: $26.96

$26.88

$26.99

2 Week Range

Now: $26.98

$7.67

$27.06

Volume

2,256,078 shs

Average Volume

1,169,678 shs

Market Capitalization

$2.62 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.17

SHOCKING Crypto Leak…

From Crypto 101 Media | Ad